Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BMYMP - FDRR: Designed For Inflation And Still Unconvincing


BMYMP - FDRR: Designed For Inflation And Still Unconvincing

Summary

  • Fidelity Dividend ETF for Rising Rates ETF invests in dividend stocks that should profit from rising rates.
  • It is better than the S&P 500 regarding valuation and quality metrics.
  • Return and dividend growth since inception are unattractive.
  • Despite rising rates, the fund has lagged competitors in 2022.

This dividend ETF (exchange-traded fund) article series aims at evaluating products regarding the relative past performance of their strategies and quality metrics of their current portfolios. As holdings and their weights change over time, updated reviews are posted when necessary.

FDRR strategy and portfolio

The Fidelity Dividend ETF for Rising Rates ETF ( FDRR ) has been tracking the Fidelity Dividend Index for Rising Rates Index since 09/12/2016. It has 123 holdings, a distribution yield of 2.75%, and a total expense ratio of 0.29%. Distributions are paid quarterly.

As described in the prospectus, the index:

“is designed to reflect the performance of stocks of large and mid-capitalization dividend-paying companies that are expected to continue to pay and grow their dividends and have a positive correlation of returns to increasing 10-year U.S. Treasury yields.”

FDRR invests mostly in U.S. based companies (94.7% of asset value), but also in Europe (4.7%) and a bit in Asia. Large companies represent about 83% of the portfolio. Technology is the heaviest sector. In fact, the fund’s sector breakdown is close to the S&P 500 ( SPY ).

FDRR sector breakdown (Chart: author; data: Fidelity)

The top 10 holdings, listed below with fundamental ratios, represent 27.9% of asset value. The fund has a significant exposure to risks related to the top 2 names: Apple (6.11%) and Microsoft (5.29%). Other holdings are below 2.5%.

Ticker

Name

Weight%

EPS growth %TTM

P/E TTM

P/E fwd

Yield%

AAPL

Apple, Inc.

6.11%

8.83

21.42

21.18

0.70

MSFT

Microsoft Corp.

5.29%

3.73

24.66

23.89

1.19

MRK

Merck & Co., Inc.

2.45%

112.19

18.44

14.98

2.64

JNJ

Johnson & Johnson

2.44%

7.38

24.38

17.43

2.58

ABBV

AbbVie, Inc.

2.13%

78.71

21.28

11.53

3.71

V

Visa, Inc.

2.05%

24.76

32.29

26.67

0.81

GILD

Gilead Sciences, Inc.

1.93%

-54.90

32.95

12.29

3.35

AMGN

Amgen, Inc.

1.90%

28.55

21.95

15.50

3.11

HD

The Home Depot, Inc.

1.82%

10.97

19.32

19.23

2.37

BMY

Bristol Myers Squibb Co.

1.79%

227.73

23.35

9.42

3.18

Historical performance

Since inception (09/12/2016), FDRR has underperformed SPY and the Vanguard Dividend Appreciation ETF ( VIG ) in total return and risk-adjusted performance (Sharpe ratio). It also shows a higher risk measured in maximum drawdown.

Total Return

Annual Return

Drawdown

Sharpe ratio

Volatility

FDRR

94.51%

11.12%

-36.52%

0.61

16.75%

SPY

104.41%

12.00%

-33.72%

0.66

16.93%

VIG

110.66%

12.53%

-31.72%

0.75

15.15%

Data calculated with Portfolio123.

The next chart compares FDRR since inception with 4 dividend growth ETFs in total return. It has underperformed all of them. The best performer in this group is the WisdomTree U.S. Quality Dividend Growth Fund ( DGRW ).

FDRR vs dividend growth funds since inception (Portfolio123)

FDRR has also lagged its competitors by a short margin in the last 12 months, despite the 10-year Treasury yield increasing from 1.76% to 3.62%.

FDRR vs dividend growth funds, last 12 months (Portfolio123)

In previous articles, I have shown how three factors may help cut the risk in a dividend portfolio: Return on Assets , Piotroski F-score , and Altman Z-score .

The next table compares FDRR since inception with a subset of the S&P 500: stocks with above-average dividend yield and ROA, a good Altman Z-score, a good Piotroski F-score and a sustainable payout ratio. It is rebalanced annually to make it comparable with a passive index.

Total Return

Annual Return

Drawdown

Sharpe ratio

Volatility

FDRR

94.51%

11.12%

-36.52%

0.61

16.75%

Dividend & quality subset

119.97%

13.31%

-35.84%

0.72

16.98%

Past performance is not a guarantee of future returns. Data Source: Portfolio123.

The dividend quality subset beats FDRR by 2.2 percentage points in annualized total return. However, the fund’s performance is real, and the subset is simulated. My core portfolio holds 14 stocks selected in this subset (more info at the end of this post).

The annual sum of distributions has increased from $0.89 in 2017 to $1.10 in 2022. The annualized dividend growth rate during this period is 4.4%: it is positive, but unattractive. In the same time, SPY shows an annualized dividend growth rate of 5.7%, and VIG is at 9.1%.

Scanning FDRR portfolio

FDRR is cheaper than the S&P 500 regarding usual valuation ratios, reported in the table below.

FDRR

SPY

Price/Earnings TTM

16.3

20.05

Price/Book

3.15

3.79

Price/Sales

2.35

2.4

Price/Cash Flow

12.27

14.97

Among 100+ holdings, 8 are risky regarding my metrics. In my ETF reviews, risky stocks are those with at least 2 red flags: bad Piotroski score, negative ROA, unsustainable payout ratio, bad or dubious Altman Z-score, excluding financials and real estate where these metrics are unreliable. They weigh less than 4% of asset value, which is a good point.

Based my calculation of weighted averages, Altman Z-score and Piotroski F-score are similar to the S&P 500. The return on assets is much better, pointing to a portfolio quality superior to the benchmark.

FDRR

SPY

Atman Z-score

3.63

3.48

Piotroski F-score

5.79

5.64

ROA % TTM

10.87

7.8

Takeaway

FDRR invests in dividend stocks that should profit from rising rates, based on the correlation of returns with 10-year U.S. Treasury yields. The fund’s sector breakdown is very close to the S&P 500. The portfolio is cheaper than the benchmark regarding usual valuation ratios, and shows a better profitability, measured in return on assets. However, FDRR has lagged the major dividend growth ETFs since inception and in the last 12 months, despite rising rates. The annualized dividend growth rate is sub-par. For transparency, a dividend-oriented part of my equity investments is split between a passive ETF allocation (FDRR is not part of it) and my actively managed Stability portfolio (14 stocks), disclosed and updated in Quantitative Risk & Value.

For further details see:

FDRR: Designed For Inflation And Still Unconvincing
Stock Information

Company Name: Bristol-Myers Squibb $2Pr
Stock Symbol: BMYMP
Market: OTC
Website: bms.com

Menu

BMYMP BMYMP Quote BMYMP Short BMYMP News BMYMP Articles BMYMP Message Board
Get BMYMP Alerts

News, Short Squeeze, Breakout and More Instantly...